New inhaled drug shows promise for asthma in early trial
NCT ID NCT05276570
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 28 times
Summary
This study tested an inhaled drug called ARO-RAGE in 127 healthy volunteers and people with asthma. The goal was to see if it is safe and how it affects lung function. Participants received one or two doses of the drug or a placebo. The results will help decide if further testing is warranted.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site 1
Nedlands, Washington, 6009, Australia
-
Research Site 1
Auckland, 1010, New Zealand
-
Research Site 1
Barcelona, 08017, Spain
-
Research Site 1
Bangkok Noi, Bangkok, 10700, Thailand
-
Research Site 2
Auckland, 1051, New Zealand
-
Research Site 2
Krakow, 31-455, Poland
-
Research Site 3
Auckland, 622, New Zealand
-
Research Site 3
Oświęcim, 32-600, Poland
Conditions
Explore the condition pages connected to this study.